• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Acuson fiscal 1995 income plummets

Article

Ultrasound vendor Acuson saw net income dive in fiscal 1995, buthigher international revenues helped to soften the blow of a 13%decline in U.S. sales. The Mountain View, CA, firm reported sales of $328.9 millionin its 1995 fiscal year (end-December),

Ultrasound vendor Acuson saw net income dive in fiscal 1995, buthigher international revenues helped to soften the blow of a 13%decline in U.S. sales.

The Mountain View, CA, firm reported sales of $328.9 millionin its 1995 fiscal year (end-December), down 6% from the $350.5million reported in fiscal 1994. Net income for the year was $7.1million compared with $18.3 million the previous year.

The results reflect Acuson's growing reliance on internationalsales. The company reported that 37% of its net sales originatedfrom its non-U.S. customers in 1995, compared with 31.7% in 1994.In the fourth quarter of 1995, 40% of its net sales came fromcustomers outside the U.S.

Acuson officials saw signs in its fourth-quarter results suggestingthat the U.S. general imaging market is stabilizing. CEO SamuelMaslak was pleased with fourth-quarter revenues of $83.6 million,a slight jump from the $83.3 million reported in the same periodthe year before. He credited the increase to positive worldwideacceptance of the ART/TCR upgrade, which was delivered to customersfor the first time in the fourth quarter.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.